{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T00:48:03Z","timestamp":1794876483414,"version":"4.9.1"},"reference-count":83,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Ampullary carcinomas (ACs) represent a rare entity, accounting for approximately 0.2% of all gastrointestinal solid tumors and 20% of all periampullary cancers (PACs). Unfortunately, few data are available regarding the optimal therapeutic strategy for ACs due to their rarity, and physicians frequently encounter significant difficulties in the management of these malignancies. In this review, we will provide an overview of current evidence on AC, especially focusing on biological features, histological characteristics, and available data guiding present and future therapeutic strategies for these rare, and still barely known, tumors.<\/jats:p>","DOI":"10.3390\/curroncol28050293","type":"journal-article","created":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T10:02:11Z","timestamp":1630576931000},"page":"3393-3402","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Ampullary Carcinoma: An Overview of a Rare Entity and Discussion of Current and Future Therapeutic Challenges"],"prefix":"10.3390","volume":"28","author":[{"given":"Alessandro","family":"Rizzo","sequence":"first","affiliation":[{"name":"Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni-15, 40128 Bologna, Italy"},{"name":"Medical Oncology Unit, \u201cMons. R. Dimiccoli\u201d Hospital, 76121 Barletta (BT), ASL BT, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Dadduzio","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, \u201cMons. R. Dimiccoli\u201d Hospital, 76121 Barletta (BT), ASL BT, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Lombardi","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, \u201cMons. R. Dimiccoli\u201d Hospital, 76121 Barletta (BT), ASL BT, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Dalia","family":"Ricci","sequence":"additional","affiliation":[{"name":"Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni-15, 40128 Bologna, Italy"},{"name":"Medical Oncology Unit, \u201cMons. R. Dimiccoli\u201d Hospital, 76121 Barletta (BT), ASL BT, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Gadaleta-Caldarola","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, \u201cMons. R. Dimiccoli\u201d Hospital, 76121 Barletta (BT), ASL BT, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.14694\/EdBook_AM.2014.34.112","article-title":"Ampullary Cancer: An Overview","volume":"34","author":"Ahn","year":"2014","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.suc.2018.12.001","article-title":"Ampullary Cancer","volume":"99","author":"Reddy","year":"2019","journal-title":"Surg. Clin. N. Am."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","article-title":"Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise","volume":"21","author":"Saha","year":"2016","journal-title":"Oncologist"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00534-004-0898-3","article-title":"Pathogenesis of carcinoma of the papilla of Vater","volume":"11","author":"Fischer","year":"2004","journal-title":"J. Hepato-Biliary-Pancreat. Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00261-015-0528-3","article-title":"MDCT and MRI of the ampulla of Vater. Part I: Technique optimization, normal anatomy, and epithelial neoplasms","volume":"40","author":"Alessandrino","year":"2015","journal-title":"Abdom. Imaging"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.suc.2016.07.012","article-title":"Palliative Care for Pancreatic and Periampullary Cancer","volume":"96","author":"Perone","year":"2016","journal-title":"Surg. Clin. N. Am."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/jso.21374","article-title":"Cancers of the ampulla of vater: Demographics, morphology, and survival based on 5625 cases from the SEER program","volume":"100","author":"Schwartz","year":"2009","journal-title":"J. Surg. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1349-7006.1994.tb02077.x","article-title":"Different Clinicopathologic Findings in Two Histologic Types of Carcinoma of Papilla of Vater","volume":"85","author":"Kimura","year":"1994","journal-title":"Jpn. J. Cancer Res."},{"key":"ref_9","unstructured":"Bosman, F., Carnerio, F., Hruban, R., and Theise, N. (2010). WHO Classification of Tumors of the Digestive System, IARC. [4th ed.]."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4251\/wjgo.v10.i11.370","article-title":"Ampulla of Vater carcinoma: Molecular landscape and clinical implications","volume":"10","author":"Pea","year":"2018","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/00000658-199705000-00015","article-title":"Adenocarcinoma of the ampulla of Vater. A 28-year experience","volume":"225","author":"Talamini","year":"1997","journal-title":"Ann. Surg."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00428-002-0625-x","article-title":"Ampulla of vater cancers: T-stage and histological subtype but not Dpc4 expression predict prognosis","volume":"441","author":"Beghelli","year":"2002","journal-title":"Virchows Arch."},{"key":"ref_13","first-page":"1641","article-title":"The clinicopathologic and immunohistochemical characteristics of ampulla of Vater carcinoma: The intestinal type is associated with a better prognosis","volume":"54","author":"Roh","year":"2007","journal-title":"Hepatogastroenterology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jamcollsurg.2008.01.028","article-title":"Tumors of the ampulla of vater: Histopathologic classification and predictors of survival","volume":"207","author":"Carter","year":"2008","journal-title":"J. Am. Coll. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/MPA.0000000000001194","article-title":"Perineural Invasion is a Strong Prognostic Moderator in Ampulla of Vater Carcinoma: A Meta-analysis","volume":"48","author":"Luchini","year":"2019","journal-title":"Pancreas"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1309\/AJCPCTCUQSYI89YT","article-title":"Phenotypic and Genotypic Characterization of Carcinomas of the Papilla of Vater Has Prognostic and Putative Therapeutic Implications","volume":"135","author":"Kohler","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/jso.22090","article-title":"Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer","volume":"105","author":"Kim","year":"2012","journal-title":"J. Surg. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41416-019-0415-8","article-title":"Can we classify ampullary tumours better? Clinical, pathological and molecular features. Results of an AGEO study","volume":"120","author":"Perkins","year":"2019","journal-title":"Br. J. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/modpathol.2016.124","article-title":"Ampullary carcinoma is often of mixed or hybrid histologic type: An analysis of reproducibility and clinical relevance of classification as pancreatobiliary versus intestinal in 232 cases","volume":"29","author":"Reid","year":"2016","journal-title":"Mod. Pathol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1200\/JCO.2012.46.8868","article-title":"Histomolecular Phenotypes and Outcome in Adenocarcinoma of the Ampulla of Vater","volume":"31","author":"Chang","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/PAS.0000000000000230","article-title":"The Utility of Immunohistochemistry in Subtyping Adenocarcinoma of the Ampulla of Vater","volume":"38","author":"Ang","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00000478-200407000-00005","article-title":"Carcinoma of the ampulla of Vater: Comparative histologic\/immunohistochemical classification and follow-up","volume":"28","author":"Zhou","year":"2004","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.pan.2021.03.005","article-title":"Long-term outcomes after pancreatoduodenectomy for ampullary cancer: The influence of the histological subtypes and comparison with the other periampullary neoplasms","volume":"21","author":"Nappo","year":"2021","journal-title":"Pancreatology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/jso.24274","article-title":"Phenotypic characterization and clinical outcome in ampullary adenocarcinoma","volume":"114","author":"Asano","year":"2016","journal-title":"J. Surg. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1046\/j.1365-2168.2002.02120.x","article-title":"The colorectal adenoma\u2013carcinoma sequence","volume":"89","author":"Leslie","year":"2002","journal-title":"J. Br. Surg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41586-019-1672-7","article-title":"The landscape of somatic mutation in normal colorectal epithelial cells","volume":"574","author":"Olafsson","year":"2019","journal-title":"Nature"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.5858\/arpa.2018-0570-RA","article-title":"Familial Adenomatous Polyposis Syndrome: An Update and Review of Extraintestinal Manifestations","volume":"143","author":"Dinarvand","year":"2019","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","article-title":"Cholangiocarcinoma\u2014Evolving concepts and therapeutic strategies","volume":"15","author":"Rizvi","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/13543784.2021.1837774","article-title":"Futibatinib, an investigational agent for the treatment of intrahepatic cholangiocarcinoma: Evidence to date and future perspectives","volume":"30","author":"Rizzo","year":"2021","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Massa, A., Varamo, C., Vita, F., Tavolari, S., Peraldo-Neia, C., Brandi, G., Rizzo, A., Cavalloni, G., and Aglietta, M. (2020). Evolution of the Experimental Models of Cholangiocarcinoma. Cancers, 12.","DOI":"10.3390\/cancers12082308"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","article-title":"Expert consensus document: Cholangiocarcinoma: Current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)","volume":"13","author":"Banales","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/liv.14086","article-title":"Clinical presentation, diagnosis and staging of cholangiocarcinoma","volume":"39","author":"Forner","year":"2019","journal-title":"Liver Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41575-020-0314-8","article-title":"Modern therapeutic approaches for the treatment of malignant liver tumours","volume":"17","author":"Petrowsky","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ccell.2015.12.012","article-title":"Genomic Sequencing Identifies ELF3 as a Driver of Ampullary Carcinoma","volume":"29","author":"Yachida","year":"2016","journal-title":"Cancer Cell"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.celrep.2015.12.005","article-title":"Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation","volume":"14","author":"Gingras","year":"2016","journal-title":"Cell Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/MPA.0b013e318258fda8","article-title":"Carcinoma of the Ampulla of Vater: Morphological and Immunophenotypical Classification Predicts Overall Survival","volume":"42","author":"Morini","year":"2013","journal-title":"Pancreas"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/SLA.0000000000001999","article-title":"Ampulla of Vater carcinoma: Sequencing analysis identifies TP53 status as a novel independent prognostic factor and potentially actionable ERBB, PI3K, and WNT pathways gene mutations","volume":"267","author":"Mafficini","year":"2018","journal-title":"Ann. Surg."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/modpathol.2015.57","article-title":"Sequencing of 279 cancer genes in ampullary carcinoma reveals trends relating to histologic subtypes and frequent amplification and overexpression of ERBB2 (HER2)","volume":"28","author":"Hechtman","year":"2015","journal-title":"Mod. Pathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4251\/wjgo.v4.i3.60","article-title":"Tumors of ampulla of Vater: A case series and review of chemotherapy options","volume":"4","author":"Romiti","year":"2012","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.pas.0000149708.12335.6a","article-title":"Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: Application of CDX2, CK17, MUC1, and MUC2","volume":"29","author":"Chu","year":"2005","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00428-007-0444-1","article-title":"Prognostic factors for ampullary adenocarcinomas: Tumor stage, tumor histology, tumor location, immunohistochemistry and microsatellite instability","volume":"451","author":"Sessa","year":"2007","journal-title":"Virchows Arch."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Rizzo, A., Ricci, A.D., and Brandi, G. (2021). PD-L1, TMB, MSI, and Other Predictors of Response to Immune Checkpoint Inhibitors in Biliary Tract Cancer. Cancers, 13.","DOI":"10.3390\/cancers13030558"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","article-title":"Immunotherapy in colorectal cancer: Rationale, challenges and potential","volume":"16","author":"Ganesh","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1097\/PAI.0000000000000575","article-title":"Microsatellite Instability: A Predictive Biomarker for Cancer Immunotherapy","volume":"26","author":"Chang","year":"2018","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00428-006-0255-9","article-title":"COX-2 expression of ampullary carcinoma: Correlation with different histotypes and clinicopathological parameters","volume":"449","author":"Perrone","year":"2006","journal-title":"Virchows Arch."},{"key":"ref_46","first-page":"1319","article-title":"Partial Resection of the Pancreatic Head and Duodenum for Management of Carcinoma of the Ampulla of Vater: A Case Report","volume":"36","author":"Liu","year":"2016","journal-title":"Anticancer Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"7970","DOI":"10.3748\/wjg.v21.i26.7970","article-title":"Management of ampullary neoplasms: A tailored approach between endoscopy and surgery","volume":"21","author":"Panzeri","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/hpb.12038","article-title":"Review of the investigation and surgical management of resectable ampullary adenocarcinoma","volume":"15","author":"Askew","year":"2013","journal-title":"HPB"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1245\/s10434-017-6025-x","article-title":"8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers","volume":"25","author":"Chun","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.surg.2017.12.018","article-title":"Validation of the eighth edition of the American Joint Committee on Cancer staging system for ampulla of Vater cancer","volume":"163","author":"Kim","year":"2018","journal-title":"Surgery"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1245\/s10434-019-07238-6","article-title":"The Prognostic Relevance of the New 8th Edition of the Union for International Cancer Control Classification of TNM Staging for Ampulla of Vater Carcinoma","volume":"26","author":"Imamura","year":"2019","journal-title":"Ann. Surg. Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.surg.2004.03.010","article-title":"Surgical management of neoplasms of the ampulla of Vater: Local resection or pancreatoduodenectomy and prognostic factors for survival","volume":"136","author":"Kuhlmann","year":"2004","journal-title":"Surgery"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1007\/s00268-010-0759-y","article-title":"Survival After Pancreaticoduodenectomy for Ampullary Cancer is not Affected by Age","volume":"34","author":"Yeh","year":"2010","journal-title":"World J. Surg."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1159\/000370251","article-title":"Factors Influencing Lymph Node Metastasis in Patients with Ampullary Adenocarcinoma","volume":"31","author":"Okano","year":"2014","journal-title":"Dig. Surg."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/bjs.9919","article-title":"Postoperative infectious complications after pancreatic resection","volume":"102","author":"Okano","year":"2015","journal-title":"Br. J. Surg."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"6847","DOI":"10.3748\/wjg.v25.i47.6847","article-title":"Influence of bile contamination for patients who undergo pancreaticoduodenectomy after biliary drainage","volume":"25","author":"Okano","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Chen, K., Pan, Y., Liu, X.L., Jiang, G.Y., Wu, D., Maher, H., and Cai, X.J. (2017). Minimally invasive pancreaticoduodenectomy for periampullary disease: A comprehensive review of literature and meta-analysis of outcomes compared with open surgery. BMC Gastroenterol., 17.","DOI":"10.1186\/s12876-017-0691-9"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1007\/s00464-019-07206-x","article-title":"Trans-duodenal ampullectomy for ampullary neoplasms: Early and long-term outcomes in 36 consecutive patients","volume":"34","author":"Nappo","year":"2019","journal-title":"Surg. Endosc."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1440-1746.2008.05578.x","article-title":"Feasibility of endoscopic papillectomy in early stage ampulla of Vater cancer","volume":"24","author":"Woo","year":"2009","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.gie.2007.03.1081","article-title":"Preoperative evaluation of ampullary neoplasm with EUS and transpapillary intraductal US: A prospective and histopathologically controlled study","volume":"66","author":"Ito","year":"2007","journal-title":"Gastrointest. Endosc."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00000658-199807000-00013","article-title":"Factors Predictive of Survival in Ampullary Carcinoma","volume":"228","author":"Howe","year":"1998","journal-title":"Ann. Surg."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00268-013-1995-8","article-title":"Adequacy of Lymph Node Retrieval for Ampullary Cancer and Its Association with Improved Staging and Survival","volume":"37","author":"Partelli","year":"2013","journal-title":"World J. Surg."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/SLA.0b013e318190c53e","article-title":"Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: A prospective randomized controlled trial","volume":"248","author":"Morak","year":"2008","journal-title":"Ann. Surg."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s11605-017-3624-6","article-title":"Association of Adjuvant Therapy with Improved Survival in Ampullary Cancer: A National Cohort Study","volume":"22","author":"Nassour","year":"2017","journal-title":"J. Gastrointest. Surg."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/jamasurg.2019.1170","article-title":"Role of Adjuvant Multimodality Therapy After Curative-Intent Resection of Ampullary Carcinoma","volume":"154","author":"Ecker","year":"2019","journal-title":"JAMA Surg."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.pan.2020.01.009","article-title":"Adjuvant therapy is associated with improved overall survival in patients with pancreatobiliary or mixed subtype ampullary cancer after pancreatoduodenectomy\u2014A multicenter cohort study","volume":"20","author":"Bolm","year":"2020","journal-title":"Pancreatology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.amjsurg.2021.04.001","article-title":"Oncologic outcomes in resected ampullary cancer: Relevance of histologic subtype and adjuvant chemotherapy","volume":"221","author":"Koprowski","year":"2021","journal-title":"Am. J. Surg."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: The next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/17474124.2017.1309290","article-title":"Intrahepatic cholangiocarcinoma: Current management and emerging therapies","volume":"11","author":"Weisbrod","year":"2017","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.21873\/anticanres.14282","article-title":"Second-line Treatment in Advanced Biliary Tract Cancer: Today and Tomorrow","volume":"40","author":"Rizzo","year":"2020","journal-title":"Anticancer. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jhep.2019.10.009","article-title":"Systemic therapies for intrahepatic cholangiocarcinoma","volume":"72","author":"Kelley","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S1470-2045(21)00027-9","article-title":"Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): A phase 3, open-label, randomised, controlled trial","volume":"22","author":"Lamarca","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Brandi, G., Frega, G., and Rizzo, A. (2021). Second-line FOLFOX chemotherapy for advanced biliary tract cancer. Lancet Oncol., 22.","DOI":"10.1016\/S1470-2045(21)00243-6"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1158\/2159-8290.CD-17-0368","article-title":"Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma","volume":"7","author":"Jusakul","year":"2017","journal-title":"Cancer Discov."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-3-030-24100-1_2","article-title":"Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer","volume":"1168","author":"Morganti","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Jain, A., Kwong, L.N., and Javle, M. (2016). Genomic Profiling of Biliary Tract Cancers and Implications for Clinical Practice. Curr. Treat. Options Oncol., 17.","DOI":"10.1007\/s11864-016-0432-2"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S1470-2045(20)30321-1","article-title":"Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): A phase 2, open-label, single-arm, multicentre basket trial","volume":"21","author":"Subbiah","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Rizzo, A., Ricci, A.D., and Brandi, G. (2021). Pemigatinib: Hot topics behind the first approval of a targeted therapy in cholangiocarcinoma. Cancer Treat. Res. Commun., 27.","DOI":"10.1016\/j.ctarc.2021.100337"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1470-2045(20)30109-1","article-title":"Pemigatinib for previously treated, locally advanced or metastatic cholangio-carcinoma: A multicentre, open-label, phase 2 study","volume":"21","author":"Sahai","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"100335","DOI":"10.1016\/j.ctarc.2021.100335","article-title":"First-line Chemotherapy in Advanced Biliary Tract Cancer Ten Years After the ABC-02 Trial: \u201cAnd Yet It Moves!\u201d","volume":"27","author":"Rizzo","year":"2021","journal-title":"Cancer Treat. Res. Commun."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"479","DOI":"10.21873\/invivo.11798","article-title":"Anti-EGFR Monoclonal Antibodies in Advanced Biliary Tract Cancer: A Systematic Review and Meta-analysis","volume":"34","author":"Rizzo","year":"2020","journal-title":"In Vivo"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Rizzo, A., and Brandi, G. (2021). TRK inhibition in cholangiocarcinoma: Trying to teach an old dog new tricks. Cancer Treat. Res. Commun., 27.","DOI":"10.1016\/j.ctarc.2021.100351"}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/28\/5\/293\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:54:28Z","timestamp":1760165668000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/28\/5\/293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":83,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["curroncol28050293"],"URL":"https:\/\/doi.org\/10.3390\/curroncol28050293","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,1]]}}}